Literature DB >> 9862763

Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.

C D Kim1, H H Kim, K W Hong.   

Abstract

We investigated the mechanism or mechanisms by which rebamipide protects against the gastric mucosal inflammation associated with Helicobacter pylori. The production of interleukin (IL)-8 in association with expression of IL-8 mRNA was greatly increased in the H. pylori-infected Kato III cells in a concentration- and time-dependent manner, whereas the secretion of IL-6 and tumor necrosis factor-alpha was not detectable. The increased production of IL-8 and expression of IL-8 mRNA were significantly inhibited by rebamipide (100-1000 microM) in a concentration-dependent manner. Formyl-methionyl-leucyl-phenylalanine (1 nM), as well as conditioned medium (CM) that was produced from H. pylori-infected Kato III cells, caused an increase in surface expression of CD11b on human neutrophils and an increase in neutrophil adhesion to the human umbilical vein endothelial cells. Rebamipide also suppressed the adherence of neutrophils to endothelial cells as well as the expression of CD11b on neutrophils induced by formyl-methionyl-leucyl-phenylalanine and CM. Furthermore, CM-induced neutrophil adhesion to the endothelial cells was significantly inhibited by IL-8-neutralizing antibody, suggesting that IL-8 is implicated in the CM-induced neutrophil adhesion to the cultured human umbilical vein endothelial cells. It is concluded that rebamipide exerts its preventive effect against H. pylori-evoked gastric mucosal cell inflammation by inhibition of the neutrophil adherence to the endothelial cells as well as by suppressing the surface expression of CD11b on neutrophils and the production of proinflammatory cytokine such as IL-8 from gastric epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862763

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Protective effect of rebamipide against Helicobacter pylori-CagA-induced effects on gastric epithelial cells.

Authors:  Kyung Hwa Lee; Jee-Yeon Kim; Woo-Kyung Kim; Dong-Hun Shin; Kyung-Un Choi; Dae Whan Kim; Woo-Jeong Lee; Jin-Hwa Choi; Soo Han Lee; Gwang Ha Kim; Geun Am Song; Tae Young Jeon; Chi Dae Kim; Ki Whan Hong; Do Youn Park
Journal:  Dig Dis Sci       Date:  2010-06-16       Impact factor: 3.199

2.  Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells.

Authors:  Jung-Yoon Choe; Ki-Yeun Park; Seung-Jin Lee; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Inflamm Res       Date:  2010-07-08       Impact factor: 4.575

3.  Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.

Authors:  Takako Nakashima; Naoya Uematsu; Kazushi Sakurai
Journal:  Support Care Cancer       Date:  2017-02-15       Impact factor: 3.603

4.  Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.

Authors:  Toshio Watanabe; Kazuhide Higuchi; Masaki Hamaguchi; Tetsuya Tanigawa; Rikimon Wada; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

5.  Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide.

Authors:  A Farhadi; A Keshavarzian; L R Fitzpatrick; E Mutlu; Y Zhang; A Banan
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

6.  Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

Authors:  T Yokota; T Ogawa; S Takahashi; K Okami; T Fujii; K Tanaka; S Iwae; I Ota; T Ueda; N Monden; K Matsuura; H Kojima; S Ueda; K Sasaki; Y Fujimoto; Y Hasegawa; T Beppu; H Nishimori; S Hirano; Y Naka; Y Matsushima; M Fujii; M Tahara
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

7.  Protective activity of geraniol against acetic acid and Helicobacter pylori- induced gastric ulcers in rats.

Authors:  Subrat Kumar Bhattamisra; Vivian Lee Yean Yan; Chin Koh Lee; Chew Hui Kuean; Mayuren Candasamy; Yun Khoon Liew; Priyadarshi Soumyaranjan Sahu
Journal:  J Tradit Complement Med       Date:  2018-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.